MDxHealth (MDXH) Non-Current Deferred Tax Liability (2022 - 2025)

MDxHealth (MDXH) posted Non-Current Deferred Tax Liability of $1.6 million for Q4 2025, down 99.9% sequentially from $1.6 billion in Q2 2025.

MDxHealth (MDXH) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends

MDxHealth (MDXH) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $1.6 million in Q4 2025.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY) and the FY2025 annual result came in at $1.6 million, changed N/A from the prior year.
Non-Current Deferred Tax Liability retreated to $1.6 million in Q4 2025 per MDXH's latest filing, from $1.6 billion in the prior quarter.
The five-year high for Non-Current Deferred Tax Liability was $1.6 billion in Q2 2025, with the low at $129000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	MDxHealth	111.80 Mn	68.64 Mn	16.61 Mn

Download Data